Cytotoxicity in cancer cell lines for the inhibition of eIF4A is generally expected since rocaglates and pateamines are originally described as compounds with potent anticancer activity by blocking cell proliferation at low nanomolar concentrations [1,26,27]. This evidence concerns the gene EIF4A1 and cancer.